Cardiology

A study from McMaster University is providing updated information related to the prevalence of hypertension and albuminuria in younger patients with type 2 diabetes.

An analysis of data from NYU Langone provides perspective into the rapid decline of emergency department presentations for acute myocardial infarction that occurred during the peak of the COVID-19 pandemic.

New data show a link between body mass index and increased risk of adverse effects from COVID-19.

New data show blood pressure lowering medication can be effective in reducing cardiovascular events in adults, regardless of blood pressure levels or history of cardiovascular risk.

An analysis comparing a national registry against ISCHEMIA enrollment criteria suggests trial eligibility represents less than 2% of all patients undergoing PCI and less than a third of patients undergoing PCI with stable ischemic heart disease.

New data find significant associations between every five-year earlier onset of diabetes and a higher hazard rate of dementia, in patients aged 35-75 years old.

Our latest case report from Brady Pregerson, MD, features a woman in her 20s presenting with dyspnea and palpitations followed by a syncopal episode. Check out the EKG and see if you can determine the correct diagnosis.

A retrospective analysis of matched cohorts has led investigators to suggest bariatric surgery should be viewed as a first-line treatment for the management of obesity in patients with type 2 diabetes.

A new study indicates history of migraine prior to entering menopause was associated with a nearly 30% greater risk of developing hypertension.

A retrospective assessment has identified a new group of genetic variants that could help identify women at an increased risk of peripartum cardiomyopathy.

April's month in review features stories related to new diabetes medications, stem cells, disparities in care of women, and how exposure to endocrine-disrupting chemicals in pregnancy can impact mental health following delivery. Check back in during the last weekend of each month for the next Endocrine Month in Review.

Data from a cohort of more than 50k French women indicates the presence of migraine prior to entering menopause was associated with a nearly 30% greater risk of developing hypertension.

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.

An analysis of more than 400 women with peripartum cardiomyopathy is providing insight into a group of genetic variants that could help identify patients who are genetically predisposed to the rare cardiovascular condition.

New data show female veterans receive poorer secondary prevention care in treating premature and extremely premature atherosclerotic cardiovascular disease, compared to male veterans.

Data from phone interviews indicate patients who had cardiovascular surgeries delayed or cancelled as a result of the COVID-19 pandemic may have experienced additional psychological stress as a result.

Data from a pair of Washington, DC-based medical centers are providing an overview of the impact gender-affirming hormone therapy can have on blood pressure in transgender individuals.

The largest study of its kind is providing insight related to changes in blood pressure seen among transgender patients initiating gender-affirming hormone therapy.

Data from a group of anticoagulant clinics in Michigan suggests aspirin use without an indication in patients with atrial fibrillation or VTE using DOACs was associated with an increased risk of bleeding and hospitalizations.

Anti-VEGF administration did increase the risk of nonocular hemorrhages, mostly in patients with AMD.

A new study finds patients with atrial fibrillation or venous thromboembolism were at higher risk of increased bleeding and hospitalization when treated with combination DOAC and aspirin.

An analysis of the CARDIA study by investigators at UCSF suggests a recommendation of 5 hours of physical activity per week may be more appropriate than the current ACC/AHA recommendation for reducing the risk of hypertension.

Dr. Gregory Weiss weighs in on the ongoing debate over using the term provider to refer to doctors, which has recently been reignited on social media.

Investigators collect study data from lengthy questionnaires relating to diet and demographics, finding that a high glycemic index correlates to more adverse effects in patients.

TIMI Group investigators found the effects of dapagliflozin on cardiovascular risk in patients with diabetes were comparable in those with markers of CKD and those without markers of CKD at baseline.